Brussels, January 27
AstraZeneca has pulled out of meeting with the EU to discuss delayed vaccine commitments to the bloc, an EU official said. The official, who asked not to be identified, said the EU would insist on them coming back to the negotiating table to explain the delay in deliveries once the Oxford-AstraZeneca vaccine gets approved for use by the European Medicines Agency.
In the US, the authorities have announced to purchase additional 200 million doses of vaccines as the country hit 25 million infections. — Agencies